[The role of antitumor drugs in treating stomach cancer patients]. / Rol' protivoopukholevykh lekarstv v lechenii bol'nykh rakom zheludka.

ABSTRACT

The treatment of advanced gastric carcinoma is a challenge to oncologists. Within the last 6-7 years several new regimens have been introduced EAP, FAMTX, MEP, MVP, ELF. Overall response rate of these schemes is 30-40%, a complete response seldom reaching 10%. Anticancer drugs significantly improve quality of life. Chemotherapy of advanced cancer is the method of choice. New combinations and regimens may appear promising.